Financial Titans Ascendant: Why XLF is Charting a Course for Record Highs

Proceed with Caution: 14 High-Flying Stocks Now Deemed Overvalued by Morningstar

Wells Fargo's Paul Christopher: Why Now is the Time to Trim Your Portfolio

Wells Fargo Crowns Axsome Therapeutics a Biotech Heavyweight with 'Overweight' Rating on Blockbuster Alzheimer's Potential

Dell's Unexpected Resilience: Why Analysts Remain Bullish After the Recent Stock Slump

Market Jitters: Why Analysts Are Toning Down Their Bullish Outlooks, Starting with Gap Inc.